These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 10766244

  • 1. PAR3 is a cofactor for PAR4 activation by thrombin.
    Nakanishi-Matsui M, Zheng YW, Sulciner DJ, Weiss EJ, Ludeman MJ, Coughlin SR.
    Nature; 2000 Apr 06; 404(6778):609-13. PubMed ID: 10766244
    [Abstract] [Full Text] [Related]

  • 2. Neutrophil proteases can inactivate human PAR3 and abolish the co-receptor function of PAR3 on murine platelets.
    Cumashi A, Ansuini H, Celli N, De Blasi A, O'Brien PJ, Brass LF, Molino M.
    Thromb Haemost; 2001 Mar 06; 85(3):533-8. PubMed ID: 11307827
    [Abstract] [Full Text] [Related]

  • 3. A dual thrombin receptor system for platelet activation.
    Kahn ML, Zheng YW, Huang W, Bigornia V, Zeng D, Moff S, Farese RV, Tam C, Coughlin SR.
    Nature; 1998 Aug 13; 394(6694):690-4. PubMed ID: 9716134
    [Abstract] [Full Text] [Related]

  • 4. Protease-activated receptor 3 is a second thrombin receptor in humans.
    Ishihara H, Connolly AJ, Zeng D, Kahn ML, Zheng YW, Timmons C, Tram T, Coughlin SR.
    Nature; 1997 Apr 03; 386(6624):502-6. PubMed ID: 9087410
    [Abstract] [Full Text] [Related]

  • 5. Regulation of plasmin-induced protease-activated receptor 4 activation in platelets.
    Mao Y, Jin J, Daniel JL, Kunapuli SP.
    Platelets; 2009 May 03; 20(3):191-8. PubMed ID: 19437337
    [Abstract] [Full Text] [Related]

  • 6. Role of thrombin signalling in platelets in haemostasis and thrombosis.
    Sambrano GR, Weiss EJ, Zheng YW, Huang W, Coughlin SR.
    Nature; 2001 Sep 06; 413(6851):74-8. PubMed ID: 11544528
    [Abstract] [Full Text] [Related]

  • 7. Proteinase-activated receptors (PARs)--the PAR3 Neo-N-terminal peptide TFRGAP interacts with PAR1.
    Kaufmann R, Schulze B, Krause G, Mayr LM, Settmacher U, Henklein P.
    Regul Pept; 2005 Feb 15; 125(1-3):61-6. PubMed ID: 15582715
    [Abstract] [Full Text] [Related]

  • 8. Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development.
    Vretenbrant K, Ramström S, Bjerke M, Lindahl TL.
    Thromb Haemost; 2007 Mar 15; 97(3):417-24. PubMed ID: 17334509
    [Abstract] [Full Text] [Related]

  • 9. Expression of protease activated receptor 3 (PAR3) is upregulated by induction of megakaryocyte phenotype in human erythroleukemia (HEL) cells.
    Cupit LD, Schmidt VA, Gnatenko DV, Bahou WF.
    Exp Hematol; 2004 Oct 15; 32(10):991-9. PubMed ID: 15504554
    [Abstract] [Full Text] [Related]

  • 10. The contribution of thrombin-induced platelet activation to thrombus growth is diminished under pathological blood shear conditions.
    Lee H, Sturgeon SA, Jackson SP, Hamilton JR.
    Thromb Haemost; 2012 Feb 15; 107(2):328-37. PubMed ID: 22187047
    [Abstract] [Full Text] [Related]

  • 11. Calcium mobilization and protein kinase C activation downstream of protease activated receptor 4 (PAR4) is negatively regulated by PAR3 in mouse platelets.
    Arachiche A, de la Fuente M, Nieman MT.
    PLoS One; 2013 Feb 15; 8(2):e55740. PubMed ID: 23405206
    [Abstract] [Full Text] [Related]

  • 12. Pepducin-based intervention of thrombin-receptor signaling and systemic platelet activation.
    Covic L, Misra M, Badar J, Singh C, Kuliopulos A.
    Nat Med; 2002 Oct 15; 8(10):1161-5. PubMed ID: 12357249
    [Abstract] [Full Text] [Related]

  • 13. Protease-activated receptor 4 uses anionic residues to interact with alpha-thrombin in the absence or presence of protease-activated receptor 1.
    Nieman MT.
    Biochemistry; 2008 Dec 16; 47(50):13279-86. PubMed ID: 19053259
    [Abstract] [Full Text] [Related]

  • 14. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin.
    Kahn ML, Nakanishi-Matsui M, Shapiro MJ, Ishihara H, Coughlin SR.
    J Clin Invest; 1999 Mar 16; 103(6):879-87. PubMed ID: 10079109
    [Abstract] [Full Text] [Related]

  • 15. Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy.
    Kuliopulos A, Covic L, Seeley SK, Sheridan PJ, Helin J, Costello CE.
    Biochemistry; 1999 Apr 06; 38(14):4572-85. PubMed ID: 10194379
    [Abstract] [Full Text] [Related]

  • 16. Release of the thrombin receptor (PAR-1) N-terminus from the surface of human platelets activated by thrombin.
    Ramachandran R, Klufas AS, Molino M, Ahuja M, Hoxie JA, Brass LF.
    Thromb Haemost; 1997 Sep 06; 78(3):1119-24. PubMed ID: 9308764
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the effects of PAR1 antagonists, PAR4 antagonists, and their combinations on thrombin-induced human platelet activation.
    Wu CC, Teng CM.
    Eur J Pharmacol; 2006 Sep 28; 546(1-3):142-7. PubMed ID: 16890935
    [Abstract] [Full Text] [Related]

  • 18. An assay for high-sensitivity detection of thrombin activity and determination of proteases activating or inactivating protease-activated receptors.
    Altrogge LM, Monard D.
    Anal Biochem; 2000 Jan 01; 277(1):33-45. PubMed ID: 10610687
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Thrombin and protease-activated receptors (PARs) in atherothrombosis.
    Martorell L, Martínez-González J, Rodríguez C, Gentile M, Calvayrac O, Badimon L.
    Thromb Haemost; 2008 Feb 01; 99(2):305-15. PubMed ID: 18278179
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.